Joseph B. Martin
#153,372
Most Influential Person Now
Joseph B. Martin's AcademicInfluence.com Rankings
Joseph B. Martinmedical Degrees
Medical
#2970
World Rank
#3417
Historical Rank
Neurology
#281
World Rank
#361
Historical Rank
Download Badge
Medical
Why Is Joseph B. Martin Influential?
(Suggest an Edit or Addition)Joseph B. Martin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Huntington's disease (1984) (2434)
- A polymorphic DNA marker genetically linked to Huntington's disease (1983) (2260)
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid (1986) (1294)
- Depressant action of TRH, LH-RH and somatostatin on activity of central neurones (1975) (418)
- The regional distribution of somatostatin, substance P and neurotensin in human brain (1981) (324)
- Morphologic and Histochemical Characteristics of a Spared Subset of Striatal Neurons in Huntington's Disease (1987) (301)
- Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease (1987) (269)
- Patterns of cell loss in Huntington's disease (1987) (232)
- Differential sparing of somatostatin‐neuropeptide y and cholinergic neurons following striatal excitotoxin lesions (1989) (208)
- Somatostatin is increased in the basal ganglia in Huntington disease (1983) (193)
- Subcellular distribution of radioimmunoassayable somatostatin in rat brain (1977) (191)
- Neuropeptides in neurological disease (1986) (160)
- Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease (1986) (153)
- A postmortem study of amino acid neurotransmitters in Alzheimer's disease (1986) (137)
- Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum (1986) (117)
- Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease (1987) (102)
- Widespread reduction of somatostatin‐like immunoreactivity in the cerebral cortex in Alzheimer's disease (1986) (100)
- BRAIN REGULATION OF GROWTH HORMONE SECRETION (1986) (98)
- Monosodium glutamate: Acute and chronic effects on rhythmic growth hormone and prolactin secretion, and somatostatin in the undisturbed male rat (1981) (91)
- Somatostatin and neuropeptide Y concentrations in pathologically graded cases of huntington's disease (1988) (88)
- Plasma Growth Hormone (GH) Response to Hypothalamic or Extrahypothalamic Electrical Stimulation (1972) (85)
- Tissue-specific sex differences in galanin-like immunoreactivity and galanin mRNA during development in the rat (1989) (78)
- Somatostatin is increased in the nucleus accumbens in Huntington's disease (1984) (78)
- Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection (1987) (78)
- Subset of neurons characterized by the presence of NADPH‐diaphorase in human substantia innominata (1987) (76)
- HYPOTHALAMIC PEPTIDES: NEW EVIDENCE FOR " PEPTIDERGIC " PATHWAYS IN THE C.N.S. (1975) (75)
- Failure of naloxone to influence physiological growth hormone and prolactin secretion (1979) (72)
- Characterization and mechanism of glutamate neurotoxicity in primary striatal cultures (1990) (70)
- Effects of neuroleptic drugs on brain somatostatin-like-immunoreactivity (1984) (69)
- CSF somatostatin‐like immunoreactivity in dementia (1986) (68)
- Topographical dopamine and serotonin distribution and turnover in rat striatum (1985) (65)
- Neuropeptides in neurologic and psychiatric disease. (1986) (65)
- The effect of somatostatin on striatal catecholamines (1984) (65)
- Effects of lesions on somatostatin-like immunoreactivity in the rat striatum (1983) (64)
- The effect of neuropeptide Y on striatal catecholamines (1986) (62)
- A detailed examination of substance P in pathologically graded cases of Huntington's disease (1988) (57)
- The effect of amphetamine on the in vivo release of dopamine, somatostatin and neuropeptide Y from rat caudate nucleus (1987) (57)
- Regional somatostatin distribution in the rat striatum (1983) (56)
- An examination of neuropeptide Y postmortem stability in an animal model simulating human autopsy conditions (1986) (55)
- Vasopressin in Alzheimer's disease: A study of postmortem brain concentrations (1986) (54)
- Beta-endorphin and somatostatin concentrations in the ventricular cerebrospinal fluid of patients with affective disorder (1986) (52)
- Human cerebrospinal fluid somatostatin in neurologic disease (1985) (51)
- Topography of nicotinamide adenine dinucleotide phosphate-diaphorase staining neurons in rat striatum (1985) (49)
- Oxytocin in Alzheimer's disease (1987) (48)
- A comparison of somatostatin and neuropeptide Y distribution in monkey brain (1987) (47)
- A comparison of regional somatostatin and neuropeptide Y distribution in rat striatum and brain (1986) (45)
- CSF vasopressin concentration is reduced in Alzheimer's disease (1986) (45)
- Caffeine stimulates β-endorphin release in blood but not in cerebrospinal fluid (1982) (45)
- D‐lactic acidosis simulating a hypothalamic syndrome after bowel bypass (1982) (44)
- The suprachiasmatic nucleus synchronizes growth hormone secretory rhythms with the light-dark cycle (1978) (44)
- Neuroactive metabolises of L‐tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid effect of tryptophan loading (1989) (43)
- Potential involvement of galanin in the regulation of fluid homeostasis in the rat (1989) (42)
- Pulsatile growth hormone secretion: inhibitory role of medial preoptic area (1978) (42)
- Somatostatin Binding Sites in Human and Monkey Brain: Localization and Characterization (1986) (37)
- Neuropeptide Y (NPY) and vasopressin (AVP) in the hypothalamo-neurohypophysial axis of salt-loaded or Brattleboro rats (1989) (35)
- Characterization of galanin-like immunoreactivity in the rat brain: Effects of neonatal glutamate treatment (1988) (34)
- Excitotoxin lesions do not mimic the alteration of somatostatin in Huntington's disease (1985) (33)
- Implications of neuropeptides in neurological diseases (1984) (30)
- Exercise and the endogenous opioids. (1981) (28)
- Effect of Chronic Treatment with Thyrotropin-Releasing Hormone (TRH) or an Analog of TRH (Linear β-Alanine TRH) on the Hypothalamic-Pituitary-Thyroid Axis (1980) (28)
- Somatostatin-281–12-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex (1986) (28)
- Depletion of striatal somatostatin by local cysteamine injection (1984) (27)
- Effects op acute administration of monosodium-l-glutamate (MSG), atropine or haloperidol on anterior pituitary hormone secretion in the rat (1978) (25)
- Effects of lesions in the amygdala and periventricular hypothalamus on striatal somatostatin-like immunoreactivity (1985) (22)
- Changes in immunoreactive vasopressin concentrations in brain regions of the rat in response to endotoxin (1983) (21)
- Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes (1986) (20)
- Molecular genetic studies in the neuropsychiatric disorders (1989) (20)
- Huntington's disease: genetically programmed cell death in the human central nervous system (1982) (19)
- Hypothalamic-pituitary responses to intracranial self-stimulation in the rat (1978) (19)
- Causal links between plasma and CSF endorphin levels in stress: Vector-ARMA analysis (1985) (19)
- Gonadal Steroid Modulation of Growth Hormone Secretory Patterns in the Rat (1987) (16)
- On the interations of galanin within the hypothalamic-pituitary axis of the rat (1991) (16)
- Immunoreactive somatostatin-281–12 is increased in Huntington's disease (1985) (15)
- Effect of dexamethasone on cortisol and prolactin responses to meals in bulimic and normal women (1988) (14)
- A comparison of the effects of kainic acid on somatostatin, substance P and dopamine in the rabbit retina (1983) (13)
- Amino acid and neuropeptide neurotransmitters in Huntington's disease cerebellum (1988) (13)
- Huntington's Disease and Neurotoxins (1992) (12)
- Neuroendocrinology and brain peptides (1982) (11)
- Reply from Neil Kowall and colleagues (1987) (8)
- Function of Neuropeptides in the Central Nervous System (1988) (8)
- Brain peptides update (1987) (8)
- Scientific American molecular neurology (1998) (8)
- Neuroendocrinology and brain peptides (1980) (7)
- Discovery of a new peptide with growth hormone releasing activity (1983) (7)
- Regulation of Growth Hormone Secretion (1986) (7)
- Effects of neuroleptic drugs on brain β-endorphin immunoreactivity (1985) (6)
- Diagnostic Dilemmas in the Management of Hypothalamic‐Pituitary‐Adrenal Disorders (1987) (5)
- Interactions Between Growth Hormone Releasing Hormone, Somatostatin and Galanin in the Control of Growth Hormone Secretion (1988) (4)
- Cerebrospinal Fluid (CSF) and Peptide Hormones edited by E. M. Rodriguez and Tj. B. van Wimersma Greidanus, S. Karger, 1982. $79.25/SFr. 132/DM 158 (viii 220 pages) ISBN 3 8055 2823 X (1982) (4)
- Antiserum to somatostatin prevents stress induced inhibition of growth hormone (GH) in the rat (1976) (3)
- Neurosecretion and Brain Peptides: Implications for Brain Functions and Neurological Disease (1981) (3)
- Microiontophoresis of Thyrotropin-Releasing Hormone (TRH). Effects on the Activity of Central Neurons (1975) (3)
- Book ReviewHandbook of Physiology: Section 7, endocrinology. Vol. 4, the pituitary gland and its neuroendocrine control; Part 1. (1975) (2)
- CNS genetic disorders: loss of function, gain of function, or something else? (1995) (2)
- Neuropeptide Abnormalities in Alzheimer’s and Huntington’s Diseases (1988) (1)
- Neuroactive peptides. Edited by Sir Arnold Burgen, H. W. Kosterlitz, L. L. Iversen, 195 pp, The Royal Society, London, England, 1980. £12.05 (1982) (1)
- Hypothalamohypophysiotropic Peptide Systems (2011) (1)
- Chemical modulation of regulatory peptides (1985) (1)
- [10] Push—pull perfusion technique in the median eminence: A model system for evaluating releasing factor dynamics (1983) (1)
- From Molecule to Brain: Molecular Neurobiology in Neurology and Psychiatry . Eric R. Kandel, Ed. Raven, New York, 1987. xxii, 199 pp., illus. $54. Association for Research in Nervous and Mental Disease Research Publications, vol. 65. (1988) (0)
- Brain Pathways: New Approaches to Structure-Function Localization (2016) (0)
- 3H‐spiroperidol binding sites in lymphocytes of patients and individuals at risk of Huntington's disease (1985) (0)
- Book Review:Perspectives in Endocrine Psychobiology. F. Brambilla, P. K. Bridges, E. Endroczi, G. Heuser (1979) (0)
- TIN anniversary of TRH (TINS, Jan., 1980, IV) (1980) (0)
- Book Review:Peptides, Hormones, and Behavior. Charles B. Nemeroff, Adrian J. Dunn (1986) (0)
- Neuroendocrinology and Brain Peptides An Emerging New Frontier in Neurobiology (1984) (0)
- 16 – Push–Pull Perfusion Technique in the Median Eminence: A Model System for Evaluating Releasing Factor Dynamics (1989) (0)
- Applications of molecular genetics to restorative neurology (1992) (0)
- Striatal Organization and Neuronal Degeneration in Huntington's Disease (1988) (0)
- Panel discussion. VII, Brain somatostatin, august 8, 1989 (1990) (0)
- Hormones and the brain (1983) (0)
- Applications of Molecular Genetics to Neuropsychiatric Disorders (1989) (0)
- Printed in the U.S.A. CAFFEINE STIMULATES B-ENDORPHIN RELEASE IN BLOOD BUT NOT IN CEREBROSPINAL FLUID (2002) (0)
- Annual Meeting, Association for Research in Nervous and Mental Diseases, Inc: Neuropeptides: Implications for Neurologic and Psychiatric Diseases (1984) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Joseph B. Martin?
Joseph B. Martin is affiliated with the following schools:
